Zydus Lifesciences informs about press release

01 Oct 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated October 1, 2022 titled ‘Zydus receives final approval from the USFDA for Sildenafil for Oral Suspension’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

887.40 -6.05 (-0.68%)
28-Jan-2026 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1621.35
Dr. Reddys Lab 1232.15
Cipla 1321.65
Zydus Lifesciences 887.40
Lupin 2132.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×